These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 31449776

  • 21. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
    Wu JF, Hsu HY, Ni YH, Chen HL, Wu TC, Chang MH.
    Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T.
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [Abstract] [Full Text] [Related]

  • 24. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
    Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB, Huang MS.
    Oncol Rep; 2011 Feb; 25(2):461-8. PubMed ID: 21152876
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity.
    Liu D, Cui L, Wang Y, Yang G, He J, Hao R, Fan C, Qu M, Liu Z, Wang M, Chen L, Li H, Guo D.
    Hepatology; 2016 Aug; 64(2):390-404. PubMed ID: 27106262
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN, Wu YJ, Tsai HW, Sun CP, Wu YH, Wu HL, Pei YN, Lu KY, Yen TT, Chang CW, Chan HL, Tao MH, Liou JY, Chang MD, Su IJ, Wang LH.
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.
    Zhang H, Huang C, Wang Y, Lu Z, Zhuang N, Zhao D, He J, Shi L.
    PLoS One; 2015 Aug; 10(5):e0127329. PubMed ID: 25993287
    [Abstract] [Full Text] [Related]

  • 30. Programmed hepatocytes cell death associated with FLIP downregulation in response to extracellular preS1/2.
    Rojas MD, Peterson DL, Barboza L, Terán-Ángel G, Labastida-Moreno CA, Berrueta L, Salmen S.
    J Med Virol; 2014 Mar; 86(3):496-504. PubMed ID: 24248906
    [Abstract] [Full Text] [Related]

  • 31. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
    Wang G, Dong XY, Tian WH, Yu CJ, Zheng G, Gao J, Wang GJ, Wei GC, Zhou YS, Wu XB.
    Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
    [Abstract] [Full Text] [Related]

  • 32. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X.
    Cancer Lett; 2017 Apr 28; 392():94-104. PubMed ID: 28192212
    [Abstract] [Full Text] [Related]

  • 33. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis.
    Arshad MI, Piquet-Pellorce C, L'Helgoualc'h A, Rauch M, Patrat-Delon S, Ezan F, Lucas-Clerc C, Nabti S, Lehuen A, Cubero FJ, Girard JP, Trautwein C, Samson M.
    Hepatology; 2012 Dec 28; 56(6):2353-62. PubMed ID: 22961755
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B Surface Antigen Activates Unfolded Protein Response in Forming Ground Glass Hepatocytes of Chronic Hepatitis B.
    Li Y, Xia Y, Cheng X, Kleiner DE, Hewitt SM, Sproch J, Li T, Zhuang H, Liang TJ.
    Viruses; 2019 Apr 25; 11(4):. PubMed ID: 31027244
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.
    Li Z, Ma L, Di L, Lin X.
    Mol Med Rep; 2021 May 25; 23(5):. PubMed ID: 33760167
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.
    J Hepatol; 2009 Sep 25; 51(3):446-57. PubMed ID: 19596477
    [Abstract] [Full Text] [Related]

  • 37. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.
    Hao C, Song JH, Hsi B, Lewis J, Song DK, Petruk KC, Tyrrell DL, Kneteman NM.
    Cancer Res; 2004 Dec 01; 64(23):8502-6. PubMed ID: 15574753
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
    Kondo Y, Ueno Y, Kobayashi K, Kakazu E, Shiina M, Inoue J, Tamai K, Wakui Y, Tanaka Y, Ninomiya M, Obara N, Fukushima K, Ishii M, Kobayashi T, Niitsuma H, Kon S, Shimosegawa T.
    J Infect Dis; 2010 Jul 15; 202(2):202-13. PubMed ID: 20533879
    [Abstract] [Full Text] [Related]

  • 39. Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
    Pelli N, Floreani A, Torre F, Delfino A, Baragiotta A, Contini P, Basso M, Picciotto A.
    Clin Exp Immunol; 2007 Apr 15; 148(1):85-9. PubMed ID: 17302732
    [Abstract] [Full Text] [Related]

  • 40. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.
    Wahl K, Siegemund M, Lehner F, Vondran F, Nüssler A, Länger F, Krech T, Kontermann R, Manns MP, Schulze-Osthoff K, Pfizenmaier K, Bantel H.
    Hepatology; 2013 Feb 15; 57(2):625-36. PubMed ID: 22991197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.